Global vaccine manufacturer focused on smallpox, mpox, and travel vaccines
Bavarian Nordic is a public vaccine company headquartered in Copenhagen with 1,400+ employees across manufacturing, regulatory, and commercial operations. The tech stack reflects a regulated-manufacturing footprint: SAP, Veeva Vault, LIMS, and HPLC dominate, paired with Microsoft enterprise tools (Dynamics 365, Azure). Current hiring is weighted toward operations, quality, and engineering roles across Europe and the US—signaling capacity expansion in manufacturing and a push to modernize IT infrastructure (notably a multi-year migration to Dynamics 365 ERP). Pain points cluster around GXP compliance, supply-chain optimization, and information security, typical for a scaled biotech moving beyond legacy systems.
Bavarian Nordic develops, manufactures, and commercializes vaccines for infectious diseases, biodefense, and travel health. The company has over 25 years in vaccine development and holds market-leading positions in smallpox and mpox vaccines, built through partnership with the U.S. Government. The business operates across five countries (Denmark, Switzerland, Germany, UK, US) with a portfolio spanning endemic diseases and public health preparedness. The company is publicly traded and structured as a fully integrated manufacturer—controlling development, production, and sales in-house—rather than relying on contract manufacturing or licensing models.
Bavarian Nordic is a global leader in smallpox and mpox vaccines developed in partnership with the U.S. Government. The portfolio also includes vaccines for travelers and endemic infectious diseases.
Bavarian Nordic uses SAP as its primary ERP with an active migration underway to Microsoft Dynamics 365 Finance and Operations, including new workflow configuration and source-to-pay process redesign.
Other companies in the same industry, closest in size